Evidence map›Paper›PMID 38675657›Full record

ArticleMolecules (Basel, Switzerland)2024

Novel Withanolides from

Lili Huang, Yingying Wei, Maowei Ni, Hongtao Hu, Luyi Xi, Chen Wang, Zhihui Zhu, Bo Yang, Huajun Zhao

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
4.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Lili HuangSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Gaoke Rd., Hangzhou 311402, China.
Yingying WeiSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Gaoke Rd., Hangzhou 311402, China.
Maowei NiThe Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou 310022, China.
Hongtao HuSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Gaoke Rd., Hangzhou 311402, China.
Luyi XiSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Gaoke Rd., Hangzhou 311402, China.
Chen WangSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Gaoke Rd., Hangzhou 311402, China.
Zhihui ZhuSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Gaoke Rd., Hangzhou 311402, China.
Bo YangSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Gaoke Rd., Hangzhou 311402, China.
Huajun ZhaoSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Gaoke Rd., Hangzhou 311402, China.
Zhejiang Chinese Medical University · CNZhejiang Cancer Hospital · CN

Funding

National Natural Science Foundation of China 82104448Natural Science Foundation of Zhejiang Province LY22H280001the Key project joint construction by Science and Technology Department of National Administration of TCM and Zhejiang Administration of TCM GZY-ZJ-KJ-23063the Key Research Project of Traditional Chinese Medicine in Zhejiang Province 2022ZZ008
6 · The paper itself

Abstract

Triple-negative breast cancer (TNBC) is a malignant breast cancer. There is an urgent need for effective drugs to be developed for TNBC.

Indexed as

Amino Acid Transport System y+ApoptosisFerroptosisTriple Negative Breast NeoplasmsTumor Suppressor Protein p53WithanolidesAnimalsCell Line, TumorCell ProliferationFemaleHumansMiceMinor Histocompatibility AntigensReactive Oxygen SpeciesXenograft Model Antitumor AssaysAmino Acid Transport System y+Minor Histocompatibility AntigensReactive Oxygen SpeciesSLC7A11 protein, humanTumor Suppressor Protein p53Withanolidesapoptosisferroptosisp53-ASCT2-SLC7A11 axisTNBCTubocapsicum anomalum

Identifiers

PMID38675657
PMCPMC11052464
OpenAlexW4394931326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.